Literature DB >> 22553266

Definitive radiotherapy for unresected adenoid cystic carcinoma of the trachea.

Lara P Bonner Millar1, Diana Stripp1, Joel D Cooper2, Stefan Both1, Paul James1, Ramesh Rengan3.   

Abstract

Adenoid cystic carcinoma is a rare malignancy that usually originates in the salivary glands of the head and neck but has rarely been known to originate in the trachea. This histology has a predilection for perineural invasion and a tendency for both local and distant recurrences. While surgical resection is the mainstay of treatment of tracheal adenoid cystic carcinoma, tumor size, location, and patient comorbidities may preclude surgery, and the optimal nonsurgical management remains undefined. In the absence of locoregional lymph node metastases, we recommend highly conformal radiotherapy alone to a dose of 80 Gy. We report on two patients with unresectable disease who were treated with definitive radiotherapy: one using conventional photons and one treated with a combination of photon and proton beams. Both patients were treated to a dose of 80 Gy with acceptable toxicities and objective clinical and radiographic response. The patient treated with conventional photons has no evidence of recurrent disease at 5 years; the patient treated with protons has continued evidence of response without evidence of disease recurrence 11 months after treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553266     DOI: 10.1378/chest.11-0925

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

1.  Adenoid cystic carcinoma of the lower trachea treated by resection of 11 of 18 rings of the total length: report of a case.

Authors:  Hiroaki Nomori; Masaru Abe; Hiroshi Sugimura; Akihiko Takeshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-27

Review 2.  Airway compromise due to adenoid cystic carcinoma obstructing the distal trachea: a review of current management and clinical trials.

Authors:  Philip Charlton; Lisa Pitkin
Journal:  BMJ Case Rep       Date:  2015-01-14

3.  Adenoid cystic carcinoma of the upper airway mimicking a thyroid tumor: A case report.

Authors:  Turki Aldrees; Abdullah Alanazi; Hanadi A Fatani; Abdulhadi Samman; Saleh F Aldhahri
Journal:  Mol Clin Oncol       Date:  2016-06-13

4.  Adenoid cystic carcinoma of head and neck: clinical predictors of outcome from a Canadian centre.

Authors:  J J Ko; J E Siever; D Hao; R Simpson; H Y Lau
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

5.  Adenoid cystic carcinoma of the tracheobronchial tree: clinicopathologic and immunohistochemical studies of 21 cases.

Authors:  Zhen Huo; Yunxiao Meng; Huanwen Wu; Jie Shen; Yalan Bi; Yufeng Luo; Jinling Cao; Zhiyong Liang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

6.  Image-guided volumetric modulated arc therapy (IG-VMAT) for unresectable ACC of the trachea: a feasible curative option.

Authors:  Rahul Lal Chowdhary; Kundan Singh Chufal; Anjali Kakria Pahuja; Manindra Bhushan; Rajpal Singh; Irfan Ahmad
Journal:  BMJ Case Rep       Date:  2019-03-21

7.  Recurrence of adenoid cystic carcinoma of the trachea treated with radical radiotherapy: A case report.

Authors:  Konrad Pawlewicz; Zbigniew Szutkowski; Andrzej Kawecki
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

8.  Proton Beam Therapy for Bronchogenic Adenoid Cystic Carcinoma: Dosimetry, Toxicities, and Outcomes.

Authors:  Vivek Verma; Liyong Lin; Charles B Simone
Journal:  Int J Part Ther       Date:  2018-07-26

9.  Laryngeal preservation in managing advanced tracheal adenoid cystic carcinoma.

Authors:  Thavakumar Subramaniam; Paul Lennon; John Kinsella; James Paul O'Neill
Journal:  Case Rep Otolaryngol       Date:  2015-03-24

10.  Tracheal adenoid cystic carcinoma mimicking a thyroid tumor: A case report.

Authors:  Wojciech Kukwa; Piotr Korzeń; Piotr Wojtowicz; Grzegorz Sobczyk; Dorota Kiprian; Andrzej Kawecki; Andrzej Kukwa; Antoni Krzeski; Cezary Szczylik; Anna M Czarnecka
Journal:  Oncol Lett       Date:  2014-06-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.